Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 15, 2008
Event: Approval of the Second Amended and Restated 2000 Stock Option and Incentive Plan at the 2008 Annual Meeting of Stockholders.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and equity plan amendments.
Material Changes
- Equity Plan Amendment: Stockholders approved an increase in the total number of shares of common stock available for issuance under the Company's 2000 Stock Option and Incentive Plan by 2,500,000 shares.
- Plan Status: The plan is now the "Second Amended and Restated 2000 Stock Option and Incentive Plan."
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, market outlook, specific risks, contingencies, or unusual items. The full text of the amended plan is incorporated by reference as Exhibit 99.1.
Investor Verification Checklist
- Verify the total number of shares authorized under the amended plan by reviewing the full text of Exhibit 99.1.
- Confirm the eligibility criteria and vesting schedules for the newly authorized 2,500,000 shares.
- Review the April 16, 2008 Proxy Statement (Schedule 14A) for the original proposal details referenced in the filing.